FDA Import Refusal AEK-3752271-9/11/1 — Novo Nordisk
The FDA refused shipment AEK-3752271-9/11/1 from Novo Nordisk (United Kingdom) on Aug 23, 2023. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 23, 2023
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75